X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA SANOFI INDIA SHASUN PHARMA/
SANOFI INDIA
 
P/E (TTM) x 123.9 30.1 412.3% View Chart
P/BV x 8.5 5.3 160.8% View Chart
Dividend Yield % 0.2 1.7 13.7%  

Financials

 SHASUN PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
SANOFI INDIA
Dec-16
SHASUN PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs944,560 2.1%   
Low Rs464,400 1.0%   
Sales per share (Unadj.) Rs214.21,028.5 20.8%  
Earnings per share (Unadj.) Rs5.3129.0 4.1%  
Cash flow per share (Unadj.) Rs15.8186.0 8.5%  
Dividends per share (Unadj.) Rs1.0068.00 1.5%  
Dividend yield (eoy) %1.41.5 94.3%  
Book value per share (Unadj.) Rs53.3753.6 7.1%  
Shares outstanding (eoy) m56.6223.03 245.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.4 7.5%   
Avg P/E ratio x13.134.7 37.7%  
P/CF ratio (eoy) x4.424.1 18.3%  
Price / Book Value ratio x1.35.9 22.0%  
Dividend payout %18.752.7 35.5%   
Avg Mkt Cap Rs m3,958103,174 3.8%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m2,1643,592 60.2%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m12,12723,686 51.2%  
Other income Rs m229708 32.4%   
Total revenues Rs m12,35624,394 50.7%   
Gross profit Rs m1,0095,281 19.1%  
Depreciation Rs m5941,313 45.2%   
Interest Rs m41515 2,767.3%   
Profit before tax Rs m2304,661 4.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-731,691 -4.3%   
Profit after tax Rs m3022,970 10.2%  
Gross profit margin %8.322.3 37.3%  
Effective tax rate %-31.736.3 -87.3%   
Net profit margin %2.512.5 19.9%  
BALANCE SHEET DATA
Current assets Rs m6,88415,673 43.9%   
Current liabilities Rs m8,4566,678 126.6%   
Net working cap to sales %-13.038.0 -34.1%  
Current ratio x0.82.3 34.7%  
Inventory Days Days6276 81.1%  
Debtors Days Days10822 482.0%  
Net fixed assets Rs m4,9708,098 61.4%   
Share capital Rs m113230 49.2%   
"Free" reserves Rs m2,87517,088 16.8%   
Net worth Rs m3,02017,356 17.4%   
Long term debt Rs m1,8170-   
Total assets Rs m13,34725,400 52.5%  
Interest coverage x1.6311.7 0.5%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.90.9 97.4%   
Return on assets %5.411.8 45.7%  
Return on equity %10.017.1 58.5%  
Return on capital %13.326.9 49.5%  
Exports to sales %46.424.5 189.3%   
Imports to sales %14.228.0 50.9%   
Exports (fob) Rs m5,6225,801 96.9%   
Imports (cif) Rs m1,7286,627 26.1%   
Fx inflow Rs m5,8437,145 81.8%   
Fx outflow Rs m2,1736,846 31.7%   
Net fx Rs m3,669299 1,227.3%   
CASH FLOW
From Operations Rs m3983,226 12.3%  
From Investments Rs m-1,635-1,555 105.1%  
From Financial Activity Rs m1,309-1,818 -72.0%  
Net Cashflow Rs m71-147 -48.4%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 3.6 14.4 25.0%  
FIIs % 17.6 14.6 120.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 10.5 377.1%  
Shareholders   20,750 15,184 136.7%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   MERCK LTD  CIPLA  ASTRAZENECA PHARMA  SUVEN LIFE  STERLING BIOTECH  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS